Related references
Note: Only part of the references are listed.Roles of Immune Cells in Hereditary Angioedema
Anne Lise Ferrara et al.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY (2021)
Multiple sclerosis - a review
R. Dobson et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
The complex alteration in the network of IL-17-type cytokines in patients with hereditary angioedema
Francesco Arcoleo et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2018)
Disease Severity, Activity, Impact, and Control and How to Assess Them in Patients with Hereditary Angioedema.
Anette Bygum et al.
FRONTIERS IN MEDICINE (2017)
RGC-32 as a potential biomarker of relapse and response to treatment with glatiramer acetate in multiple sclerosis
Adam M. Kruszewski et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients
Laura D. Serpero et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
The mechanism of action of glatiramer acetate treatment in multiple sclerosis
Michael K. Racke et al.
NEUROLOGY (2010)
Hereditary angioedema: New findings concerning symptoms, affected organs, and course
K Bork et al.
AMERICAN JOURNAL OF MEDICINE (2006)